Acute Coronary Syndrome
Conditions
Interventions
The test group:Danhong Injection and Naoxintong capsule, conventional treatment of western medicine
The control group:Glucose Injection and placebo of Naoxintong capsule, conventional treatment of western medicine
Sponsors
Guangdong Provincal Hospital of Traditional Chinese medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Being in line with the Western standard of Acute Coronary Syndrome; 2. Fit with the TCM diagnosis of Qi deficiency and blood stasis and phlegm syndrome; 3. Patients who are aged between 30 to 75 yrs old, and have already signed the Consent form.
Exclusion criteria
Exclusion criteria: 1. People who has an allergy to Danhong injection or Naoxintong capsule; 2. People who are severe arrhythmia, such as type II second degree atrioventricular block, sick sinus syndrome (SSS), etc. and severe hypotension or hypertension, severe heart failure (above heart function lever III, and not under control), acute cardiac tamponade, and acute pulmonary oedema, etc.; 3. People who have any medical conditions like merge hemorrhage cerebrovascular accident (CVA), gastrointestinal bleeding, Diabetes complications or severe liver and kidney problems; 4. People who have any medical condition like hemophilia, severe thrombocytopenia, or dysfunction of blood coagulation; 5. People with cancer or mental illness; 6. People who need the Coronary Artery Bypass Grafting (CABG).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Endothelin, ET;Nitric oxide, NO;von Willebrand factor, vWF;flow mediated dilation, FMD; | — |
Countries
China
Contacts
Public ContactBojun Chen
Outcome results
None listed